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Critical value policies used by clinical laboratories 
ensure that caregivers are notified of patients’ life-
threatening results. Lundberg[1] was the first author 
to define critical values as results that may lead to 
adverse outcomes for patients if clinicians were not 
notified urgently of the critical result. He developed a system whereby 
laboratories identified critical results and contacted the clinician caring 
for the patient.[1] Critical value reporting has subsequently become an 
accreditation requirement, with most laboratories having implemented 
critical value policies as a quality assurance practice.
Although critical value reporting is widely accepted, it poses 
certain challenges. Each laboratory is responsible for establishing 
critical values policies in conjunction with local clinical opinion, 
review of laboratory practice and the relevant published literature. 
A number of international publications have described critical value 
lists. In the early 1990s, Kost[2-3] published surveys of adult and 
paediatric critical values from medical centres in the USA, and more 
recently the College of American Pathologists[4] compared the critical 
values of 163 of its participants. Although these resources are useful 
for critical value assessment, they may not be clinically relevant to 
South Africa (SA). Moreover, local lists are not readily available.
A survey was therefore designed to determine the critical value 
policies for haematology tests in clinical laboratories in SA.
Methods
Study design
A survey form was sent to 136 identified laboratories across SA 
in January 2013. Of these, 36 (26.5%) responded. Critical values 
were defined as results requiring urgent notification. Participating 
laboratories were asked to provide high and low critical values for 
haematology tests for adults and children and to document their 
critical value reporting policy. The results were reviewed against 
published international studies comparing critical values across a 
large number of laboratories.
Statistical analysis
The survey findings were recorded on an Excel spreadsheet. The 
mean, standard deviation and range were calculated for each test.
Results
Data were collected from 36 laboratories, of which 11.1% (n=4) were 
private, 33.3% (n=12) were affiliated to academic institutions, and 
55.6% (n=20) were peripheral or regional National Health Laboratory 
Service (NHLS) laboratories.
Critical value policies
Table 1 summarises the critical value policies of the laboratories 
surveyed. All confirmed that they had a critical value standard 
operating policy based on the following sources: local clinical opinion 
(63.9%, n=23); the published literature (8.3%, n=3); local opinion 
and the published literature (19.4%, n=7); and review of laboratory 
practice (8.3%, n=3).
Critical value reporting
Of the laboratories, 97.2% (n=35) indicated that reporting was 
commonly undertaken by the technologist on duty. In addition, 
Critical value reporting: A survey of 36 clinical 
laboratories in South Africa
 
E Schapkaitz, MB BCh, FCPath (Haem), MMed (Haem); Z Mafika, MB ChB
 
Department of Molecular Medicine and Haematology, National Health Laboratory Service and University of the Witwatersrand, 
Johannesburg, South Africa
Corresponding author: E Schapkaitz (elise.schapkaitz@nhls.ac.za)
Objective. Critical value policies are used by clinical laboratories to decide when to notify caregivers of life-threatening results. Despite 
their widespread use, critical value policies have not been published locally. A survey was designed to determine critical value policies for 
haematology tests in South Africa.
Methods. A survey was carried out on 136 identified laboratories across South Africa in January 2013. Of these, 36 responded. Data collected 
included critical value policies, critical values for haematology parameters, and critical value reporting.
Results. Of the 36 laboratories surveyed, 11.1% (n=4) were private, 33.3% (n=12) were affiliated to academic institutions and 55.6% (n=20) 
were peripheral or regional National Health Laboratory Service laboratories. All the laboratories confirmed that they had a critical value 
policy, and 83.3% of such policies were derived from local clinical opinion. Mean low and high critical limits for the most frequently listed 
tests were as follows: haemoglobin <6 and >20 g/dl, platelet count <41 and >1 000 ×109/l, white cell count <2 and >46×109/l, activated partial 
thromboplastin time >101 seconds, and international normalised ratio >6. In almost all cases critical value reporting was performed by the 
technologist on duty (97.2%). The majority of laboratories required that the person notified of the critical value be the doctor who ordered 
the test or the caregiver directly involved in the patient’s care (83.3%); 73.3% of laboratories indicated that they followed an algorithm if 
the doctor/caregiver could not be reached.
Conclusion. Each laboratory is responsible for establishing clinically relevant critical limits. Clinicians should be involved in developing the 
laboratory’s critical value policy. The findings of this survey may be of value to local laboratories that are in the process of establishing or 
reviewing critical value policies.
S Afr Med J 2014;104(1):65-67. DOI:10.7196/SAMJ.7057
RESEARCH
66       January 2014, Vol. 104, No. 1
19.4% of the laboratories (n=7) authorised reporting by a call centre. 
All laboratories reported critical results telephonically as well as via 
an automated method such as a fax, e-mail or sms (5.6%, n=2). The 
majority of the laboratories required that the person notified of the 
critical value be the doctor or nurse directly involved in the patient’s 
care, and/or the person who ordered the test (83.3%, n=30). A 
minority of laboratories (16.7%, n=6) permitted reporting of critical 
values to any nurse, doctor on call or clerical staff member (or did 
not specify).
Of the 15 laboratories that responded to this question, 73.3% 
(n=11) reported following an algorithm in the event that the caregiver 
could not be reached. This resulted in additional time spent. The 
steps in the algorithms included contacting the departmental head 
or hospital superintendent (18.1%, n=2) or the doctor on call (45.5%, 
n=5), delivering the critical values via messenger or automated 
message (18.1%, n=2), or phoning at least three times (18.1%, n=2).
Critical values for haematology tests
Mean low and high critical limits for the most frequently listed 
tests were as follows: haemoglobin <6 and >20 g/dl, platelet count 
<41 and >1 000×109/l, white cell count <2 and >46×109/l, activated 
partial thromboplastin time (aPTT) >101 seconds, and international 
normalised ratio (INR) >6 (Table 2). Laboratories also included 
presence of malaria (72.2%, n=26), haemolysis (16.7%, n=6) and/
or primitive cells/blasts (30.6%, n=11) in their critical value lists 
on peripheral blood review. A minority of laboratories reported 
additional critical values for coagulation assays, namely fibrinogen 
(13.9%, n=5), d-dimer (13.9%, n=5), coagulation factors (2.8%, 
n=1) and anti-Xa (2.8%, n=1). Specific critical limits for children 
and neonates were reported by 5.6% (n=2) and 13.9% (n=5) of 
laboratories, respectively.
In addition, 5.6% of laboratories (n=2) reported paediatric critical 
values that were similar to their adult values.
Table 3 shows the comparison of the mean, low and high critical 
limits of the three laboratory categories. The private laboratories 
reported a stricter cut-off for the mean lower limit for haemoglobin 
Table 1. Characteristics of critical value policies
Critical value policies Laboratories, n (%)
Written policies for establishing critical values
Yes 36 (100)
No 0 (0)
Source
Local clinical opinion 23 (63.9)
Published literature 3 (8.3)
Local clinical opinion and literature 7 (19.4)
Review of laboratory practice 3 (8.3)
Population-specific critical values
Yes 4 (11.4)
No 31 (88.6)
Critical value reporting
Technologist on the bench 35 (97.2)
 Senior staff (lab manager, registrars, 
pathologists)
12 (33.3)
Call centre 7 (19.4)
Automated method 2 (5.6)
Receiving critical values
 Caregiver (nurse or doctor) directly 
involved in the patient’s care and/or doctor 
who ordered the test
30 (83.3)
Staff nurse, doctor on call or clerical staff 6 (16.7)
Algorithm in place if the caregiver is unreachable
Yes 11 (73.3)
No 4 (26.7)
Table 3. Comparison of adult critical value means
Test
Critical value, mean (±SD)
Low High
Academic Peripheral Private Academic Peripheral Private
Haemoglobin (g/dl) 6 (±0.9) 5 (±0.8) 6.8 (±1.0) 20 (±0.8) 20 (±0.3) 20 (±0)
Platelet count (×109/l) 33 (±22.6) 43 (±19.7) 47.5 (±5.0) 1 000 (±0) 1 000 (±0) 1 000 (±0)
White cell count (×109/l) 2 (±1.0) 3 (±0.8) 2 (±0) 44 (±7.4) 48 (±4.1) 37.5 (±17.7)
aPTT (seconds) - - - 104 (±47.5) 115 (±10.0) 121 (±84.1)
INR - - - 6 (±1.6) 6 (±1.0) 4.4 (±0.5)
SD = standard deviation; aPTT = activated partial thromboplastin time; INR = international normalised ratio.
Table 2. Adult and paediatric mean critical values
Test
Critical value, mean (±SD)
Low High
Adult critical values
Haemoglobin (g/dl) 6 (±0.9) 20 (±0.5)
Platelet count (×109/l) 41 (±19.8) 1 000 (±0)
White cell count (×109/l) 2 (±0.9) 46 (±7.0)
aPTT* (seconds) - 101 (±45.4)
INR - 6 (±1.5)
Paediatric critical values
Haemoglobin (g/dl) 9 (±1.1) 29 (±9.2)
Platelet count (×109/l) 40 (±34.6) -
White cell count (×109/l) 4 (±0) 53 (±11.6)
SD = standard deviation; aPTT = activated partial thromboplastin time; 
INR = international normalised ratio.
* Laboratories need to consider the aPTT results specific for their reagent and analyser 
when setting critical limits. Nine of the laboratories reported a prolonged aPTT on 
heparin therapy as a critical value.
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and platelet count, and for the upper limit for INR compared with 
the academic and peripheral and regional NHLS laboratories. For 
example, the mean lower limit for haemoglobin was 6.8 g/ dl for 
private laboratories, 6.0 g/dl for laboratories affiliated to academic 
institutions, and 5.0 g/dl for peripheral and regional NHLS 
laboratories. Similarly, the mean upper limit for the INR was 4.4 for 
private laboratories and 6 for the laboratories affiliated to academic 
institutions and the peripheral and regional NHLS laboratories.
Discussion
The national focus is currently on improving laboratory commitment 
to service, efficiency and patient safety. Critical value reporting is an 
important laboratory quality indicator. The laboratories surveyed 
indicated that policies were in place for reporting critical values in 
accordance with accreditation requirements. In the absence of local 
published literature, the majority of laboratories have relied on local 
clinical opinions to develop critical value limits. The findings of this 
survey may be of value to local laboratories that are in the process of 
establishing or reviewing their critical values policies.
All laboratories surveyed reported adult critical values for the 
commonly performed haematology tests, namely haemoglobin, 
platelet count, white cell count, INR and aPTT, that may reflect life-
threatening emergencies. The ranges for the critical values reported 
were very wide. For example, the lower limits for haemoglobin and 
platelet count ranged from 4 to 8 g/dl and from 10 to 100×109/l, 
respectively. Laboratories may wish to review their given critical 
value(s) for clinical relevance in their specific settings.
The variability of the mean critical values between the three 
laboratory categories is shown in Table 3. The private laboratories 
reported a stricter cut-off for the mean lower limit for haemoglobin 
and platelet count and the mean upper limit for INR compared 
with the academic, peripheral and regional NHLS laboratories. 
International surveys report similar cut-offs to those reported by the 
private laboratories. Kost[2] and Wagar et al.[4] reported mean lower 
limits for haemoglobin of 6.6 and 6.9 g/dl, respectively, as well as a 
mean upper limit for the INR of 4.0.
In addition to being developed in conjunction with the published 
literature, it is important that critical value policies are reviewed by 
local clinicians to ensure that cut-off values are clinically relevant. As 
seen in the landmark Transfusion Requirements in Critical Care trial,[5] 
a restrictive transfusion trigger of <7 g/dl for younger (<55 years) 
and less ill (APACHE II score <20) patients is a clinically relevant 
limit. Clinical trials, however, show a wide variation in triggers for 
transfusion.[6] Similarly, an INR of >5 is a clinically relevant limit 
because it is associated with an increased risk of bleeding.[7] An INR >5 
requires urgent intervention, such as withholding warfarin doses or 
administering specific treatment, such as vitamin K, fresh-frozen plasma 
or prothrombin complex concentrates, to reverse the effect of warfarin. [7] 
This serves as a further example of the important role clinicians play in 
developing their local laboratory’s critical value policies.
Critical value policies require notification of the abnormal result to 
someone who can react appropriately. A minority of laboratories 
allowed reporting of critical values to someone other than the 
direct caregiver, e.g. a nurse, a doctor on call or a member of the 
clerical staff, with the risk that the recipient may know little about 
the patient’s clinical condition and of the clinical significance of 
the critical result. The majority, however, required that the person 
notified of the critical value be the doctor who ordered the test or the 
caregiver directly involved in the patient’s care, as is recommended 
in the literature.[8] Furthermore, significantly, the laboratory staff 
member can interpret the result with the direct caregiver, and suggest 
further investigations.[9]
The reporting of critical values generates a significant workload.[10] 
Published studies report that 1 - 15% of coagulation tests are critical 
values requiring urgent notification.[11] Laboratories may therefore 
need to rely on call centres to perform these administrative functions 
in the future.
Conclusion
Each laboratory is responsible for establishing clinically relevant 
critical limits and ensuring that the appropriate caregivers are rapidly 
notified, so that quality patient care can be administered. Clinicians 
should be involved in developing the laboratory’s critical value policy. 
Critical value calls are costly for laboratories, as extensive time is 
required by skilled staff to handle reporting. Automated notification 
systems may need to be considered and investigated.
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